Gene regulation by mRNA editing.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Importance of Transcript Variants in Transcriptome Analyses.Cells · 2024
   Article
2. Biological significance of RNA editing in cells.Molecular biotechnology · 2012
   Review
3. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.American journal of human genetics · 2002
   Article
4. Message therapy: gene therapy that targets mRNA sequence and stability.American journal of human genetics · 1997
   Review

Corrections and comments

• Comment on
  A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors.1997

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as